Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000246387

Medchemexpress LLC 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide | 1012054-59-9 | MFCD15528940 | 99.1% | 434.49 g/mol | C24H26N4O4 | 25 MG
SDP

Supplier:  Medchemexpress LLC HY1022325MG

Encompass_Preferred

CUDC-101 is a small-molecule inhibitor that concurrently targets histone deacetylases (HDACs) and receptor tyrosine kinases EGFR and HER2, used in biochemical and cell-based research. It is supplied as a solid and as DMSO solutions and is intended for research use only (not for human or clinical use).

  • Dual inhibition of HDAC and EGFR/HER2 for pathway-specific studies.
  • Potent activity with reported IC50s: HDAC 4.4 nM, EGFR 2.4 nM, HER2 15.7 nM.
  • High purity (~99%) suitable for sensitive assays.
  • Available in small milligram quantities and DMSO solutions for assay preparation.
  • Formulated for laboratory research; follow safety data sheet guidance for handling.

Catalog No. 50-002-46387


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.